Cudmore2016. effects of a synbiotic in adults with chronic …

INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION 7

Figure 3. Average and confidence interval of stool consistency using a weighted average distance (weighted according to the fre- quency of each stool type) for stool type away from type 01 on the Bristol Stool Scale.

Table 5. Pairwise comparison of Lepicol versus Placebo on QOL score with results from the pre- treatment used as the baseline covariate. 95% Confidence Interval for Difference

% ScoreMean Difference (Lepicol - Placebo)

QOL category All categories

p -Value Lower Bound Upper Bound Effect size

 12.033  15.176  10.509  8.595  13.060  28.488

.051 .030 .055 .155 .067 .003

 24.096  28.855  21.229  20.516  27.036  47.224

0.031

0.514 0.545 0.492 0.364 0.464

Intensity of symptoms

 1.498 0.212

Effect on daily life

Feelings

3.326 0.916

Life with constipation

Satisfaction 0.749 The analysis was carried out by standardising the total scores of the subcategories. A negative % score indicates an improvement in QOL.  9.752

(painful bowel movements, burning sensation, bleed- ing/tearing) and stool symptoms (incomplete bowel movement, stool too hard, stool too small, straining and false alarm). While the overall constipation scores improved for both groups throughout the study ( p ¼ .001), constipation symptoms were lower by 12.32 % in the Lepicol group versus placebo group ( p ¼ .039) as shown in Table 6. When broken into the three categories it was found that on aver- age subjects ’ abdominal symptoms were improved by 13.1 % ( p ¼ .005) and rectal symptoms by 8.7 % ( p ¼ .044) in the Lepicol group over placebo. Stool

with a medium effect size of .749). These data are shown in Figure 4, which indicates that the effect size for each of the QOL sub-categories is greater in the Lepicol group than in the placebo. Constipation symptoms The constipation symptoms were assessed using the PAC-SYM questionnaire at the start (visit 2) and end (visit 3) of the 4 week intervention period. This questionnaire is divided into three categories with a total of 12 questions; abdominal symptoms (discom- fort, pain, bloating, cramps), rectal symptoms

Powered by